• SENSEX 73,123.83
    -125.56 (--0.17%)
  • BANKNIFTY 54,287.35
    -638.35 (--1.16%)
  • SBI
    950.75 900.80(%)
  • Tonbo Imaging
    1,209.85 1,209.85(%)
  • Cyient
    1,268.00 1,268.00(%)
  • NSE
    1,640.25 1,640.25(%)
  • Bonfiglioli Tran
    527.40 527.40(%)
  • IndusInd Bank
    831.35 750.45(%)
  • Eternal
    317.50 344.75(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 940.00(%)
  • Swiggy
    174.90 174.90(%)
  • Persistent Systems
    5,688.80 4,242.65(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,003.65(%)
  • PC Jeweller
    17.08 7.45(%)
  • Bharat Forge
    1,680.45 1,265.00(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glenmark Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20600.0
  • ISIN : INE935A01035
2,166.60 -32 (-1.45%)
  • As on 24 Oct 2026 (EOD)

  • Today’s Low

    2,101.60

  • Today’s High

    2,203.80

  • Open

    2,196.00

  • Perv Close

    2,198.50

  • 52W Low

    1,792.60

  • 52W High

    2,537.60

Key Indicators

  • P/E(TTM)

    41.17

  • Mar.Cap (₹Cr.)

    61,146.80

  • Div & Yield %

    0.23

  • Book Value(₹)

    855.71

  • Debt-Equity Ratio

    -1.45

  • AGM Date

    23-Oct-2026

  • EPS

    51.73

  • P/E Ratio

    41.17

Financials Ratios

  • Debt-Equity Ratio

    0.34

  • Mar.Cap (₹Cr.)

    61,146.80

  • RONW (%)

    -50.87

  • ROCE (%)

    12.05

Score Board

  • Equity (₹ in Cr.)

    28.22

  • BV (₹)

    855.70

  • Sales( ₹ in Cr.)

    8,440.10

  • NP (in Cr.)

    942.47

  • NP Var(%)

    -47.0

  • Div%

    500.0

  • CPS (₹)

    41.80

  • EPS (₹)

    33.40

  • Traded Value (₹ in Lakhs)

    60,102.57

  • 52 Week High

    2,537.60

  • 52 Week Low

    1,792.60

  • Price BSE

    2130.0

  • Price NSE

    2,167.00

  • Market Capital( in Cr.)

    60,102.57

  • P/C Ratio

    51.00

  • P/E Ratio

    63.80

  • Price Vs.BV

    33.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 8,440.10 9,226.41 7,891.12 8,220.66 8,141.58 7,567.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 8,440.10 9,226.41 7,891.12 8,220.66 8,141.58 7,567.93
Other Income 772.02 356.37 6,238.36 985.94 1,044.96 470.13
Stock Adjustments 105.42 -44.48 103.07 31.37 16.13 -5.24
Total Income 9,317.54 9,538.30 14,232.55 9,237.97 9,202.67 8,032.82
EXPENDITURE :            
Raw Materials 3,184.37 3,154.65 3,313.19 3,427.07 3,425.06 2,944.53
Power and Fuel Cost 112.65 114.62 104.92 95.09 91.34 80.49
Employee Cost 1,790.41 1,603.50 1,434.78 1,346.51 1,193.20 1,107.40
Other Manufacturing Expenses 370.83 372.36 375.32 304.66 347.04 267.26
Selling and Administration Expenses 1,593.61 1,305.30 1,199.17 1,246.10 1,062.89 914.37
Miscellaneous Expenses 2,217.11 566.49 325.15 855.71 349.97 358.30
Employee Benefit Expenses 1,790.41 1,603.50 1,434.78 1,346.51 1,193.20 1,107.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 9,268.97 7,116.92 6,752.52 7,275.13 6,469.50 5,672.35
Operating Profit 48.57 2,421.38 7,480.02 1,962.84 2,733.18 2,360.47
Interest 78.75 48.73 277.11 206.82 236.04 265.90
Gross Profit -30.18 2,372.65 7,202.91 1,756.02 2,497.14 2,094.57
Depreciation 235.89 218.63 202.16 184.15 159.70 150.82
Profit Before Tax -266.07 2,154.02 7,000.75 1,571.87 2,337.44 1,943.75
Current Tax -724.52 600.76 1,049.99 386.93 411.08 343.62
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 659.25 -57.09 783.46 -23.83 -71.42 -49.31
Reported Net Profit -200.80 1,610.35 5,167.29 1,208.77 1,997.79 1,649.45
Extraordinary Items -1,143.27 -152.91 3,742.26 -369.56 354.02 59.87
Adjusted Net Profit 942.47 1,763.26 1,425.03 1,578.33 1,643.77 1,589.58
Adjustment below Net Profit -16.96 -6.47 -4.76 0.63 1.61 2.48
P & L Balance brought forward 22,581.15 21,088.13 16,002.82 14,863.96 12,921.86 11,340.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 266.25 110.87 77.22 70.54 57.30 70.54
P & L Balance carried down 22,097.15 22,581.15 21,088.13 16,002.82 14,863.96 12,921.86
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 500.00 250.00 250.00 250.00 250.00 250.00
Dividend Per Share(Rs) 5.00 2.50 2.50 2.50 2.50 2.50
Earnings Per Share-Unit Curr -7.12 57.07 183.11 42.84 70.80 58.46
Earnings Per Share(Adj)-Unit Curr -7.12 57.07 183.11 42.84 70.80 58.46
Book Value 855.79 868.35 814.01 633.57 593.21 524.84
Book Value(Adj)-Unit Curr 855.79 868.35 814.01 633.57 593.21 524.84

Shareholding Pattern

  • Promoter Group

    46.65%

  • Public Share Holding

    53.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,415,386 1.21 3,415,386 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 128,241,936 45.44 128,241,936 1
Others 0 0.00 0 0
Sub Total 131,657,322 46.65 131,657,322 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 107,037 0.04 107,037 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 359,371 0.13 359,371 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 60,699,270 21.51 60,699,270 394
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,373,093 0.84 2,373,093 19
Mutual Funds / UTI 44,067,459 15.61 44,067,459 38
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,971,590 1.05 2,971,590 45
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 110,577,820 39.18 110,577,820 502
2] Non Institution
Bodies Corporate 7,283,744 2.58 7,283,744 1,494
Clearing Members 22,029 0.01 22,029 5
Directors of their Relatives 23,898 0.01 23,898 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,298,997 0.81 2,294,997 6,685
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 517,729 0.18 517,729 3,478
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,921,148 2.45 6,921,148 12
Individuals holding nominal share capital up to Rs. 1 lakh 22,536,139 7.99 22,330,805 196,211
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 99,688 0.04 99,688 17
Others 286,158 0.10 286,158 3
Sub Total 39,989,530 14.17 39,780,196 207,906
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 282,224,672 100.00 282,015,338 208,414

Company Background

Glenmark Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Glenmark Pharmaceuticals Ltd
  • BSE Code : 20600.0
  • ISIN : INE935A01035

  • Incorporation Year

    1977

  • Registered Office

    B/2 Mahalaxmi Chambers
    22 Bhulabhai Desai Road, Mumbai,
    Maharashtra-400026

  • Telephone

    91-22-40189999

  • FAX

    91-22-40189986

  • Chairman

    Glenn Saldanha

  • Managing Director

    Glenn Saldanha

  • Company Secretary

    Rashmi Khandelwal.

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glenmark Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glenmark Pharma. 2,129.60 9,212.12 8,440.10 293.74 6.30
Abbott India 25,004.30 7,217.19 6,929.05 32.91 43.78
Astrazeneca Phar 5,988.15 2,304.07 2,275.58 88.26 27.86
Glaxosmi. Pharma 2,404.80 3,932.76 3,790.20 38.42 58.17
Novartis India 1,834.75 393.10 354.33 46.33 15.94
Cipla 1,337.00 20,102.60 18,979.95 35.14 13.88
Bliss GVS Pharma 628.50 773.53 729.81 58.41 12.51
Amrutanjan Healt 487.65 520.13 502.55 26.12 24.16
Fermenta Biotec. 454.90 474.15 450.25 21.24 18.77
Guj. Themis Bio. 327.25 168.25 165.82 87.50 18.05
Ambalal Sarabhai 34.60 19.52 3.94 64.07 6.77